Targeting OSMR in glioma stem cells

Oncotarget. 2017 Mar 7;8(10):16103-16104. doi: 10.18632/oncotarget.15066.

Authors

Sushmetha Mohan¹, Azad Bonni², Arezu Jahani-Asl¹

Affiliations

¹ Department of Oncology, Integrated Program in Neuroscience, McGill University, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
² Department of Neuroscience, Washington University School of Medicine, St. Louis, MO, USA.

No abstract available

Keywords: EGFRvIII; Neuroscience; OSMR; STAT3; glioblastoma; tumor stem cells.

Publication types

Editorial

MeSH terms

Animals
Brain Neoplasms / metabolism*
Cell Proliferation
Drug Design
ErbB Receptors / genetics
ErbB Receptors / metabolism
Gene Expression Profiling
Glioblastoma / metabolism*
Glioma / metabolism*
Humans
Mice
Mice, SCID
Neoplasm Transplantation
Neoplastic Stem Cells / cytology*
Oncostatin M Receptor beta Subunit / metabolism*
Phosphorylation
Signal Transduction
Treatment Outcome

Substances

OSMR protein, human
Oncostatin M Receptor beta Subunit
ErbB Receptors